Torrent Pharma Inc. Recalls

All product recalls associated with Torrent Pharma Inc..

Get alerts for this brand

Recall Summary

Total Recalls

84

Past Year

2

Class I (Serious)

1

Most Recent

May 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 84 recalls

Fluoxetine Tablets (Torrent Pharma) - CGMP Nitrosamine Deviation (2025)

CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Class IIModerate

FDAMay 27, 2025Nationwide• Torrent Pharma Inc.

Fluoxetine Tablets (Torrent Pharma) - CGMP Nitrosamine Deviation (2025)

CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Class IIModerate

FDAMay 27, 2025Nationwide• Torrent Pharma Inc.

Pantoprazole Sodium Tablets (Torrent) – Tablet Cracking (2022)

CGMP deviations: tablets cracking

Class II

Moderate

FDAApr 11, 2022Nationwide• Torrent Pharma Inc

Carbamazepine Tablets (Torrent) - Dissolution Failure (2021)

Failed Dissolution Specifications

Class IIModerate

FDADec 2, 2021Nationwide• Torrent Pharma Inc.

Telmisartan-Hydrochlorothiazide (Torrent) - Superpotent Medication (2021)

Superpotent; Hydrochlorothiazide

Class IIILow

FDADec 1, 2021Nationwide• Torrent Pharma Inc.

Anagrelide Capsules (Torrent Pharma) – Failed Dissolution (2020)

Failed Dissolution Specifications

Class IHigh

FDANov 25, 2020Nationwide• Torrent Pharma Inc

Carbamazepine Tablets (Torrent Pharma) – Dissolution Failure (2020)

Failed Dissolution Specifications

Class IIModerate

FDAMay 11, 2020Nationwide• Torrent Pharma Inc.

Losartan Potassium Tablets 100mg (Torrent) – NMBA Impurity (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.

Class IIModerate

FDASep 19, 2019Nationwide• Torrent Pharma Inc.

Losartan Potassium Tablets 50mg (Torrent) – NMBA Impurity (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.

Class IIModerate

FDASep 19, 2019Nationwide• Torrent Pharma Inc.

Losartan/Hydrochlorothiazide Tablets 50mg (Torrent) – NMBA Impurity (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.

Class IIModerate

FDASep 19, 2019Nationwide• Torrent Pharma Inc.

Losartan/Hydrochlorothiazide Tablets 100mg (Torrent) – NMBA Impurity (2019)

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.

Class IIModerate

FDASep 19, 2019Nationwide• Torrent Pharma Inc.

Anagrelide Capsules (Torrent) - impurity specification (2019)

Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.

Class IIModerate

FDASep 6, 2019Nationwide• Torrent Pharma Inc.